Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.
Giil LM, Vedeler CA, Kristoffersen EK, Nordrehaug JE, Heidecke H, Dechend R, Schulze-Forster K, Muller DN, von Goetze VS, Cabral-Marques O, Riemekasten G, Vogelsang P, Nygaard S, Lund A, Aarsland D.
Giil LM, et al. Among authors: kristoffersen ek.
J Alzheimers Dis. 2017;59(3):929-939. doi: 10.3233/JAD-170245.
J Alzheimers Dis. 2017.
PMID: 28697567